Marché de la purification des vecteurs viraux au Moyen-Orient et en Afrique, par produit et services (produits et services), type (vecteurs rétroviraux, virus vaccinaux, vecteurs adénoviraux, vecteurs viraux adéno-associés, lentivirus et autres), flux de travail (traitement en amont et traitement en aval), technique de purification (ultracentrifugation à gradient de densité, ultrafiltration, précipitation, systèmes d'extraction à deux phases et chromatographie), échelle d'opération (préclinique / clinique et commerciale), méthode d'administration (in vivo et ex vivo), indication de la maladie (cancer, troubles génétiques, maladies infectieuses , maladies vétérinaires et autres), application (antisens et ARNi, thérapie génique, thérapie cellulaire et vaccinologie), utilisateur final (sociétés de biotechnologie, sociétés pharmaceutiques, organisations de recherche sous contrat, organisation de développement et de fabrication sous contrat (CDMO) et instituts universitaires / de recherche), pays (Arabie saoudite, Afrique du Sud, Émirats arabes unis, Israël, Égypte et reste du Moyen-Orient et de l'Afrique) Tendances et prévisions de l'industrie 2028
Analyse et perspectives du marché : marché de la purification des vecteurs viraux au Moyen-Orient et en Afrique
Le marché de la purification des vecteurs viraux devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 12,4 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 22,17 millions USD d'ici 2028. La demande croissante de vecteurs viraux agit comme un moteur pour le marché de la purification des vecteurs viraux
Les biologistes moléculaires utilisent fréquemment des vecteurs viraux pour introduire du matériel génétique dans les cellules. Cette procédure peut être réalisée in vivo (à l'intérieur d'un organisme vivant) ou en culture cellulaire (in vitro). Les virus ont développé des mécanismes moléculaires spécialisés pour transporter efficacement leur génome à l'intérieur des cellules qu'ils infectent. La transduction est l'introduction de gènes ou d'autre matériel génétique par un vecteur et les cellules infectées sont dites transduites.
L'émergence de la COVID-19 et la demande de vaccins viraux stimulent le marché de la purification des vecteurs viraux. Le manque d'évolutivité constitue un frein pour le marché de la purification des vecteurs viraux. Le nombre croissant de maladies infectieuses constitue une opportunité pour le marché de la purification des vecteurs viraux. La pénurie de personnel qualifié constitue un défi pour le marché de la purification des vecteurs viraux.
Le rapport sur le marché de la purification des vecteurs viraux fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits, les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché de la purification des vecteurs viraux, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché de la purification des vecteurs viraux
The viral vector purification market is categorized into nine notable segments which are based on the product & services, type, workflow, purification technique, scale of operation, delivery method, disease indication, application and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product & services, the viral vector purification market is segmented into products and services. In 2021, products segment is expected to dominate the viral vector purification market due to availability of diverse range of innovative solutions for vector purification.
- On the basis of type, the viral vector purification market is segmented into retroviral vectors, vaccine virus, adenoviral vectors, adeno-associated viral vectors, lentivirus and other. In 2021, adeno-associated viral vectors segment is expected to dominate the viral vector purification market due to broad range of infectivity of AAV.
- On the basis of workflow, the viral vector purification market is segmented into upstream processing and downstream processing. In 2021, upstream processing segment is expected to dominate the viral vector purification market because the viral vectors produced using this process can be harvested from cells in a short window of time post transfection.
- On the basis of purification technique, the viral vector purification market is segmented into density-gradient ultracentrifugation, ultrafiltration, precipitation, two-phase extraction systems and chromatography. In 2021, chromatography segment is expected to dominate the viral vector purification market because it has been widely used for purification of vaccines and gene therapy vectors.
- On the basis of scale of operation, the viral vector purification market is segmented into preclinical / clinical and commercial. In 2021, preclinical / clinical segment is expected to dominate the viral vector purification market due to rising investment for research and development activities by major healthcare organizations.
- On the basis of delivery method, the viral vector purification market is segmented into in vivo and ex vivo. In 2021, in vivo segment is expected to dominate the viral vector purification market due to its high availability and process reliability.
- On the basis of disease indication, the viral vector purification market is segmented into cancer, genetic disorders, infectious diseases, veterinary disease and other. In 2021, genetic disorders segment is expected to dominate the viral vector purification market owing to the rising incidence and prevalence of genetic disorders.
- On the basis of application, the viral vector purification market is segmented into antisense & RNAi, gene therapy, cell therapy and vaccinology. In 2021, gene therapy segment is expected to dominate the viral vector purification market due to broad range of applications in medical sector.
- On the basis of end user, the viral vector purification market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations, contract development and manufacturing organization (CDMO) and academic/ research institutes. In 2021, academic/ research institutes segment is expected to dominate the viral vector purification market due to increasing initiative activities by various healthcare organizations and government bodies to encourage research endeavour.
Middle East and Africa Viral Vector Purification Market Country Level Analysis
Middle East and Africa viral vector purification market is analysed and market size information is provided by the country, product & services, type, workflow, purification technique, scale of operation, delivery method, disease indication, application and end user as referenced above.
The countries covered in the Middle East and Africa viral vector purification market report are Saudi Arabia, South Africa, UAE, Israel, Egypt and rest of Middle East and Africa.
Middle East and Africa is expected to grow with the fastest CAGR in the forecast period as in the Middle East and Africa’s countries, the demand for viral vector purification is increasing very rapidly due to rapidly increasing population and increasing healthcare expenditure. Saudi Arabia is expected to dominate in Middle East and Africa viral vector purification market as Saudi Arabia is one of the leading countries in the Middle East and Africa utilizing advanced viral vector purification products for treatments.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Viral Vector Purification Market
Le marché de la purification des vecteurs viraux vous fournit également une analyse détaillée du marché pour la croissance de chaque pays. De plus, il fournit des données détaillées sur la croissance des ventes de purification des vecteurs viraux, des partenariats, des acquisitions et des accords de distribution entre les acteurs du marché de la purification des vecteurs viraux de la région Moyen-Orient et Afrique. Les données sont disponibles pour la période historique de 2011 à 2019.
Analyse du paysage concurrentiel et des parts de marché de la purification des vecteurs viraux
Le paysage concurrentiel du marché de la purification des vecteurs viraux fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement du produit, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise vers le marché de la purification des vecteurs viraux au Moyen-Orient et en Afrique.
Les principaux acteurs couverts dans le rapport sur le marché de la purification des vecteurs viraux au Moyen-Orient et en Afrique sont Applied Biological Materials Inc., Creative Biolabs, Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., uniQure NV, BioVision Inc. parmi d'autres acteurs nationaux. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.
De nombreux contrats et accords sont également initiés par les entreprises du monde entier, ce qui accélère également le marché de la purification des vecteurs viraux.
Par exemple,
- En janvier 2021, Thermo Fisher Scientific Inc. a annoncé avoir finalisé l'acquisition de l'activité de fabrication de vecteurs viraux de Novsep en Belgique, ce qui aidera l'entreprise à diversifier davantage son marché.
La collaboration, les coentreprises et d’autres stratégies des acteurs du marché améliorent l’impression de l’entreprise sur le marché de la purification des vecteurs viraux, ce qui offre également l’avantage à l’organisation d’améliorer la croissance de ses ventes.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 DRIVERS
4.1.1 RISING DEMAND FOR VIRAL VECTORS
4.1.2 AVAILABILITY OF DIVERSE RANGE OF INNOVATIVE SOLUTIONS FOR VECTOR PURIFICATION
4.1.3 EMERGENCE OF COVID-19 AND DEMAND FOR VACCINE DEVELOPMENT
4.1.4 BENEFITS OF VIRAL VECTORS FOR GENE THERAPY
4.1.5 GROWING USAGE OF AAV VECTORS FOR DELIVERY OF SIRNA IN MAMMALIAN CELLS
4.2 RESTRAINTS
4.2.1 LACK OF SCALABILITY
4.2.2 LIMITATIONS OF DOWNSTREAM PURIFICATION
4.3 OPPORTUNITIES
4.3.1 GROWING CANCER BURDEN WORLDWIDE
4.3.2 RISING NUMBER OF INFECTIOUS DISEASES
4.3.3 GROWING GERIATRIC POPULATION
4.3.4 RISING HEALTH CONSCIOUSNESS AND INCREASING SPENDING ON HEALTHCARE
4.4 CHALLENGES
4.4.1 BIOLOGICAL CHALLENGES
4.4.2 SHORTAGE OF SKILLED PERSONNEL
5 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: REGULATIONS
1 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES
1.1 OVERVIEW
1.2 PRODUCTS
1.2.1 RESIN
1.2.2 KIT
1.2.3 REAGENT
1.2.4 PREPACKED COLUMN
1.2.5 CASSETTE
1.2.6 CAPSULE
1.2.7 FILTER PLATE
1.3 SERVICES
2 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE
2.1 OVERVIEW
2.2 CHROMATOGRAPHY
2.2.1 AFFINITY CHROMATOGRAPHY
2.2.2 ION-EXCHANGE CHROMATOGRAPHY
2.2.3 SIZE-EXCLUSION CHROMATOGRAPHY
2.2.4 HYDROPHILIC INTERACTION CHROMATOGRAPHY
2.3 DENSITY-GRADIENT ULTRACENTRIFUGATION
2.4 ULTRAFILTRATION
2.5 PRECIPITATION
2.6 TWO-PHASE EXTRACTION SYSTEMS
3 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY TYPE
3.1 OVERVIEW
3.2 ADENO-ASSOCIATED VIRAL VECTORS
3.3 ADENOVIRAL VECTORS
3.3.1 MASTADENOVIRUS
3.3.2 AVIADENOVIRUS
3.3.3 SIADENOVIRUS
3.3.4 ATADENOVIRUS
3.3.5 ICHTADENOVIRUS
3.4 LENTIVIRUS
3.5 RETROVIRAL VECTORS
3.5.1 REPLICATION DEFECTIVE
3.5.2 REPLICATION-COMPETENT
3.6 VACCINE VIRUS
3.7 OTHER
4 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW
4.1 OVERVIEW
4.2 UPSTREAM PROCESSING
4.3 DOWNSTREAM PROCESSING
5 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION
5.1 OVERVIEW
5.2 PRECLINICAL / CLINICAL
5.3 COMMERCIAL
6 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY MODE
6.1 OVERVIEW
6.2 IN VIVO
6.3 EX VIVO
7 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION
7.1 OVERVIEW
7.2 GENETIC DISORDERS
7.2.1 THALASSEMIA
7.2.2 CYSTIC FIBROSIS
7.2.3 TAY-SACHS DISEASE
7.2.4 SICKLE CELL ANEMIA
7.2.5 OTHERS
7.3 INFECTIOUS DISEASES
7.3.1 MEASLES VIRUS
7.3.2 VESICULAR STOMATITIS VIRUS
7.3.3 NOVEL ADENOVIRUSES
7.3.4 CYTOMEGALOVIRUS
7.3.5 OTHERS
7.4 VETERINARY DISEASE
7.5 CANCER
7.6 OTHER
8 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 GENE THERAPY
8.2.1 RECOMBINANT PROTEIN EXPRESSION
8.2.2 FUNCTIONAL ASSAYS
8.2.3 PROTEIN CHARACTERIZATION
8.2.4 IN VITRO TRANSCRIPTION
8.2.5 OTHERS
8.3 CELL THERAPY
8.4 VACCINOLOGY
8.5 ANTISENSE & RNAI
9 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY END USER
9.1 OVERVIEW
9.2 ACADEMIC/ RESEARCH INSTITUTES
9.3 PHARMACEUTICAL COMPANIES
9.4 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)
9.5 BIOTECHNOLOGY COMPANIES
9.6 CONTRACT RESEARCH ORGANIZATIONS
10 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY GEOGRAPHY
10.1 MIDDLE EAST & AFRICA
10.1.1 SOUTH AFRICA
10.1.2 SAUDI ARABIA
10.1.3 UAE
10.1.4 EGYPT
10.1.5 ISRAEL
10.1.6 REST OF MIDDLE EAST & AFRICA
11 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
12 COMPANY PROFILE
12.1 THERMO FISHER SCIENTIFC INC.
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 CYTIVA (A SUBSIDIARY OF DANAHER)
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 MERCK KGAA
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 AGILENT TECHNOLOGIES, INC.
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 FUJIFILM DIOSYNTH BIOTECHNOLOGIES
12.5.1 COMPANY SNAPSHOT
12.5.2 PRODUCT PORTFOLIO
12.6 ADDGENE
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 ALDEVRON
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 APPLIED BIOLOGICAL MATERIALS INC.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 BIA SEPARATIONS
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.1 BIO-RAD LABORATORIES, INC.
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENT
12.11 BIOVISION INC.
12.11.1 COMPANY SNAPSHOT
12.11.2 PRODUCT PORTFOLIO
12.11.3 RECENT DEVELOPMENT
12.12 BATAVIA BIOSCIENCES B.V.
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENT
12.13 CREATIVE BIOGENE
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
12.14 CREATIVE BIOLABS
12.14.1 COMPANY SNAPSHOT
12.14.2 SERVICE PORTFOLIO
12.15 IDT BIOLOGIKA GMBH
12.15.1 COMPANY SNAPSHOT
12.15.2 PRODUCT PORTFOLIO
12.15.3 RECENT DEVELOPMENTS
12.16 PROBIOGEN AG
12.16.1 COMPANY SNAPSHOT
12.16.2 PRODUCT PORTFOLIO
12.16.3 RECENT DEVELOPMENTS
12.17 SIRION-BIOTECH GMBH
12.17.1 COMPANY SNAPSHOT
12.17.2 PRODUCT PORTFOLIO
12.17.3 RECENT DEVELOPMENTS
12.18 TAKARA BIO INC.
12.18.1 COMPANY SNAPSHOT
12.18.2 REVENUE ANALYSIS
12.18.3 PRODUCT PORTFOLIO
12.18.4 RECENT DEVELOPMENTS
12.19 UNIQURE N.V.
12.19.1 COMPANY SNAPSHOT
12.19.2 REVENUE ANALYSIS
12.19.3 PRODUCT PORTFOLIO
12.19.4 RECENT DEVELOPMENT
12.2 WAISMAN BIOMANUFACTURING
12.20.1 COMPANY SNAPSHOT
12.20.2 PRODUCT PORTFOLIO
12.20.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
Liste des tableaux
LIST OF TABLES
TABLE 1 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA SERVICES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA DENSITY-GRADIENT ULTRACENTRIFUGATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA ULTRAFILTRATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA PRECIPITATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA TWO-PHASE EXTRACTION SYSTEMS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA ADENO-ASSOCIATED VIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA LENTIVIRUS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA VACCINE VIRUS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA OTHER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA UPSTREAM PROCESSING IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA DOWNSTREAM PROCESSING IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA PRECLINICAL / CLINICAL IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA COMMERCIAL IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA IN VIVO IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA EX VIVO IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA VETERINARY DISEASE IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA CANCER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA OTHER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA CELL THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA VACCINOLOGY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA ANTISENSE & RNAI IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA ACADEMIC/ RESEARCH INSTITUTES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA PHARMACEUTICAL COMPANIES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 54 MIDDLE EAST & AFRICA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 55 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 MIDDLE EAST & AFRICA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 57 MIDDLE EAST & AFRICA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 63 MIDDLE EAST & AFRICA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 MIDDLE EAST & AFRICA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 67 SOUTH AFRICA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 68 SOUTH AFRICA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 69 SOUTH AFRICA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 70 SOUTH AFRICA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 71 SOUTH AFRICA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 72 SOUTH AFRICA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 73 SOUTH AFRICA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 74 SOUTH AFRICA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 75 SOUTH AFRICA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 76 SOUTH AFRICA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 77 SOUTH AFRICA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 78 SOUTH AFRICA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 79 SOUTH AFRICA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 80 SOUTH AFRICA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 81 SOUTH AFRICA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 82 SOUTH AFRICA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 83 SAUDI ARABIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 84 SAUDI ARABIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 85 SAUDI ARABIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 86 SAUDI ARABIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 87 SAUDI ARABIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 SAUDI ARABIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 SAUDI ARABIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 90 SAUDI ARABIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 91 SAUDI ARABIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 92 SAUDI ARABIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 93 SAUDI ARABIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 94 SAUDI ARABIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 95 SAUDI ARABIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 96 SAUDI ARABIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 97 SAUDI ARABIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 98 SAUDI ARABIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 99 UAE VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 100 UAE PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 101 UAE VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 102 UAE CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 103 UAE VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 104 UAE RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 105 UAE ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 106 UAE VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 107 UAE VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 108 UAE VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 109 UAE VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 110 UAE GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 111 UAE INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 112 UAE VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 UAE GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 114 UAE VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 115 EGYPT VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 116 EGYPT PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 117 EGYPT VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 118 EGYPT CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 119 EGYPT VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 120 EGYPT RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 121 EGYPT ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 122 EGYPT VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 123 EGYPT VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 124 EGYPT VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 125 EGYPT VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 126 EGYPT GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 127 EGYPT INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 128 EGYPT VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 129 EGYPT GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 130 EGYPT VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 131 ISRAEL VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 132 ISRAEL PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 133 ISRAEL VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 134 ISRAEL CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 135 ISRAEL VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 136 ISRAEL RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 137 ISRAEL ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 138 ISRAEL VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 139 ISRAEL VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 140 ISRAEL VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 141 ISRAEL VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 142 ISRAEL GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 143 ISRAEL INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 144 ISRAEL VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 145 ISRAEL GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 146 ISRAEL VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 147 REST OF MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
Liste des figures
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: SEGMENTATION
FIGURE 12 AVAILABILITY OF DIVERSE RANGE OF INNOVATIVE SOLUTIONS FOR VECTOR PURIFICATION IS DRIVING THE MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET
FIGURE 15 ESTIMATED NUMBER OF NEW CASES IN MALE AND FEMALE (ALL AGE GROUP) WORLDWIDE IN 2018
FIGURE 1 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, 2020
FIGURE 2 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, 2021-2028 (USD MILLION)
FIGURE 3 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, CAGR (2021-2028)
FIGURE 4 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 5 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, 2020
FIGURE 6 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, 2021-2028 (USD MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, CAGR (2021-2028)
FIGURE 8 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, LIFELINE CURVE
FIGURE 9 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY TYPE, 2020
FIGURE 10 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY TYPE, 2021-2028 (USD MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 12 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 13 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, 2020
FIGURE 14 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, 2021-2028 (USD MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, CAGR (2021-2028)
FIGURE 16 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, LIFELINE CURVE
FIGURE 17 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, 2020
FIGURE 18 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, CAGR (2021-2028)
FIGURE 20 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, LIFELINE CURVE
FIGURE 21 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, 2020
FIGURE 22 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, 2021-2028 (USD MILLION)
FIGURE 23 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, CAGR (2021-2028)
FIGURE 24 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, LIFELINE CURVE
FIGURE 25 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, 2020
FIGURE 26 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, 2021-2028 (USD MILLION)
FIGURE 27 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, CAGR (2021-2028)
FIGURE 28 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, LIFELINE CURVE
FIGURE 29 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, 2020
FIGURE 30 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 31 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 32 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY END USER, 2020
FIGURE 34 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 35 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY END USER, CAGR (2021-2028)
FIGURE 36 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET: SNAPSHOT (2020)
FIGURE 38 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2020)
FIGURE 39 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 40 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 41 MIDDLE EAST & AFRICA VIRAL VECTOR PURIFICATION MARKET: BY TYPE (2021-2028)
FIGURE 42 MIDDLE EAST AND AFRICA VIRAL VECTOR PURIFICATION MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
